Clinical trial No longer in our active list Interventional Ages 8 Months to 36 Months

Intensive leg exercise to improve walking in children with diplegia

Official title: Randomized Controlled Trial of Early Intensive Leg Exercise to Improve Walking in Children With Diplegia From Encephalopathy of Prematurity

Run by University of Alberta · NCT03672877 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study tests if intensive leg exercises can help young children with spastic diplegia walk better compared to regular physiotherapy.

Quick facts

Study typeInterventional
Ages8 Months to 36 Months
SexAll
Enrollment60 (estimated)
SponsorUniversity of Alberta
Academic / other
Locations2 sites (Calgary, Alberta and 1 other locations)
Trial IDNCT03672877 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 8 months to 3 years with bilateral motor impairment of the lower extremities due to periventricular white matter injury.

Probably not a fit

Patients with substantial upper extremity involvement, uncontrolled epilepsy, or recent botulinum toxin injections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares three months of intensive leg exercise to standard physiotherapy in young children with spastic diplegia. It aims to improve gross motor function by providing active physical therapy, which is typically infrequent in current treatment approaches. Children aged 8 months to 3 years will be randomly assigned to either immediate treatment or a delay group, allowing researchers to assess the effectiveness of early intervention. The study will measure various outcomes, including motor development and walking proficiency, and will follow participants until they are four years old to evaluate long-term benefits.

Why it matters

Potential benefit: If successful, this approach could significantly enhance walking abilities and overall motor function in children with spastic diplegia.

How similar studies have gone: Previous studies have shown promising results with intensive therapy for children with similar conditions, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Bilateral motor impairment of the lower extremities
* Periventricular white matter injury from encephalopathy of prematurity
* Able to stand with some support

Exclusion Criteria:

* Substantial upper extremity involvement - Manual Abilities Classification System (MACS) Level ≥3
* Uncontrolled epilepsy or infantile spasms in the past 6 months
* Cardiovascular or musculoskeletal complications that preclude participation in intensive exercise
* Botulinum toxin-A (BTX-A) injections in the legs in the last 6 months

Where it's running

  • Alberta Children's Hospital
    Calgary, Alberta, Canada
    Recruiting
  • University of Alberta
    Edmonton, Alberta, Canada
    Recruiting

Study contacts

  • Principal investigator: Jaynie Yang, Phd — Universtiy of Alberta
  • Study coordinator: Donna Livingstone, BScPT
  • Email: carre@ualberta.ca
  • Phone: 780-492-4858

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.